ArticleFrontiers in oncology2023

Neoadjuvant osimertinib and chemotherapy for stage IIIA primary pulmonary carcinosarcoma with EGFR 19DEL mutation: A case report.

Hongming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.